237 related articles for article (PubMed ID: 6976793)
41. Occurrence of acute leukaemia in myeloproliferative disorders.
Rosenthal DS; Moloney WC
Br J Haematol; 1977 Jul; 36(3):373-82. PubMed ID: 268210
[TBL] [Abstract][Full Text] [Related]
42. [THE PLACE OF OSTEOMYELOSCLEROSIS AMONG THE MYELOPROLIFERATIVE DISEASES].
STOBBE H
Dtsch Gesundheitsw; 1965 Jan; 20():13-20. PubMed ID: 14265017
[No Abstract] [Full Text] [Related]
43. Acute leukaemia after hydroxyurea therapy in polycythaemia vera and allied disorders: prospective study of efficacy and leukaemogenicity with therapeutic implications.
Weinfeld A; Swolin B; Westin J
Eur J Haematol; 1994 Mar; 52(3):134-9. PubMed ID: 8168592
[TBL] [Abstract][Full Text] [Related]
44. Sex and age as prognostic factors in essential thrombocythemia.
Randi ML; Fabris F; Rossi C; Tison T; Barbone E; Girolami A
Haematologica; 1992; 77(5):402-4. PubMed ID: 1483589
[TBL] [Abstract][Full Text] [Related]
45. Multimeric composition of plasma von Willebrand factor in chronic myeloproliferative disorders.
Tatewaki W; Takahashi H; Shibata A
Clin Lab Haematol; 1988; 10(4):417-25. PubMed ID: 3150698
[TBL] [Abstract][Full Text] [Related]
46. Defining the thrombotic risk in patients with myeloproliferative neoplasms.
Vianello F; Battisti A; Cella G; Marchetti M; Falanga A
ScientificWorldJournal; 2011 May; 11():1131-7. PubMed ID: 21623459
[TBL] [Abstract][Full Text] [Related]
47. [HEMORRHAGIC THROMBOCYTHEMIA AND THE "MYELOPROLIFERATIVE SYNDROME"].
VON KNORRING
Nord Med; 1964 Dec; 72():1443-6. PubMed ID: 14211013
[No Abstract] [Full Text] [Related]
48. Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk-stratification, and management.
Tefferi A
Am J Hematol; 2013 Jun; 88(6):507-16. PubMed ID: 23695894
[TBL] [Abstract][Full Text] [Related]
49. [Metamorphosis of chronic myeloproliferative diseases].
Butoianu E; Nicoară S; Coliţă A; Ursea C; Berceanu S
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(3):223-32. PubMed ID: 6140716
[No Abstract] [Full Text] [Related]
50. The risk of thrombosis in essential thrombocythemia and polycythemia vera.
Pearson TC
Semin Oncol; 2002 Jun; 29(3 Suppl 10):16-21. PubMed ID: 12096353
[TBL] [Abstract][Full Text] [Related]
51. [Essential thrombocythemia. Contribution of the V617F JAK2 mutation to the pathophysiology, diagnosis and outcome].
Brière J
Bull Acad Natl Med; 2007 Mar; 191(3):535-48. PubMed ID: 18072652
[TBL] [Abstract][Full Text] [Related]
52. Abnormalities of von Willebrand factor in myeloproliferative disease: a relationship with bleeding diathesis.
Fabris F; Casonato A; Grazia del Ben M; De Marco L; Girolami A
Br J Haematol; 1986 May; 63(1):75-83. PubMed ID: 3085704
[TBL] [Abstract][Full Text] [Related]
53. [Clinical characterization of essential thrombocythemia in comparison with other myeloproliferative diseases and reactive thrombocytoses].
Jahn M; Zönnchen B; Köpcke W; Hehlmann R
Klin Wochenschr; 1988 Mar; 66(5):190-8. PubMed ID: 3163063
[TBL] [Abstract][Full Text] [Related]
54. Myeloperoxidase-deficient polymorphonuclear leucocytes (VII): Incidence in untreated myeloproliferative disorders.
Bendix-Hansen K
Scand J Haematol; 1986 Jan; 36(1):8-10. PubMed ID: 3006224
[TBL] [Abstract][Full Text] [Related]
55. Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients.
Thiele J; Kvasnicka HM
Ann Hematol; 2003 Mar; 82(3):148-52. PubMed ID: 12634946
[TBL] [Abstract][Full Text] [Related]
56. [Essential thrombocytosis].
Van Camp G
Acta Clin Belg; 1989; 44(1):31-6. PubMed ID: 2763782
[TBL] [Abstract][Full Text] [Related]
57. Low incidence of familial occurrence of thrombocythaemia and/or thrombocytosis.
Randi ML; Fabris F; Visentin I; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(5):695-9. PubMed ID: 2465250
[TBL] [Abstract][Full Text] [Related]
58. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
Iványi JL; Marton E; Plander M
Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
[TBL] [Abstract][Full Text] [Related]
59. Polycythemia vera, myeloid metaplasia with terminal myelogenous leukemia.
LITWINS J; GREENWALD L; GREENWALD HP
Bulletin NY Med Coll; 1955; 18():38-45. PubMed ID: 13329577
[No Abstract] [Full Text] [Related]
60. Occurrence of haemorrhagic and thrombotic events in myeloproliferative disorders: a retrospective study of 108 patients.
Grossi A; Rosseti S; Vannucchi AM; Rafanelli D; Ferrini PR
Clin Lab Haematol; 1988; 10(2):167-75. PubMed ID: 3416575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
